Potentiation of Liver Function Recovery and Its Regeneration by the Modulation of Extracellular Matrix During the Early Phase after Liver Transplantation

肝移植术后早期细胞外基质调节促进肝功能恢复及其再生

基本信息

项目摘要

1) Long-term ethanol consumption enhances an ability to produce cytokine-induced neutrophil chemoattractant (CINC) in the rat liver : Rats were pair-fed a liquid diet containing ethanol or dextrose for 6-8 wk. They were given lipopolysaccharide (LPS) and chemokine mRNA expression in the liver was evaluated. CINC mRNA expressions in the liver after 2 and 6 hr were significantly higher in the ethanol-fed group than the control. Female alcoholic rats showed higher level of CINC mRNA in the liver than the male rats 2 hr after LPS injection. It was shown that gonadectomy totally abolished the gender difference in CINC mRNA of the liver. We conclude that CINC induction may be responsible for alcoholic hepatitis, and that the difference in ability to produce CINC is a factor contributory to the gender-difference of alcoholic liver disease.2) Alcoholic fatty liver differentially induces CINC and hepatic necrosis after ischemia-reperfusion (I/R) : Next, we investigated a cascade of events from transcription factor activation to necrosis through cytokine-induction and apoptosis in fatty liver after I/R. Rats with alcoholic or non-alcoholic fatty liver were subjected to warm I/R and compared with control rats. Rats with alcoholic fatty liver developed severe hepatic necrosis after I/R, compared to rats with non-alcoholic fatty liver or control. Hepatic apoptosis increased in the 2 fatty liver models compared with the control. Alcoholic fatty liver showed a rapid increase in NF-κB binding activity at 1 hr after I/R, which preceded an increased expression of TNF-α and CINC. In contrast, non-alcoholic fatty liver showed neither NF-κB activation nor cytokine induction after I/R. Our results indicate that alcoholic fatty liver may differentially induce CINC production and hepatic necrosis after I/R. Furthermore, the present study suggests that apoptosis be responsible for the progression to hepatic necrosis when neutrophils are activated and recruited to the liver.
1)长期摄入乙醇可提高大鼠肝脏产生细胞因子诱导的中性粒细胞化学引诱剂(CINC)的能力:大鼠分别饲喂含有乙醇或葡萄糖的液体饲料6-8周。给予脂多糖(LPS),观察肝脏趋化因子mRNA的表达。2、6 h后,乙醇喂养组肝脏cnc mRNA表达量显著高于对照组。注射LPS后2小时,雌性酒精大鼠肝脏cnc mRNA水平高于雄性大鼠。结果表明,性腺切除术完全消除了肝脏cnc mRNA的性别差异。我们得出结论,CINC诱导可能是酒精性肝炎的原因,而产生CINC能力的差异是导致酒精性肝病性别差异的一个因素。2)酒精性脂肪肝在缺血再灌注(I/R)后诱导CINC和肝坏死的差异:接下来,我们研究了I/R后脂肪肝从转录因子激活到细胞因子诱导和凋亡的级联事件。对酒精性和非酒精性脂肪肝大鼠进行热I/R,并与对照大鼠进行比较。与非酒精性脂肪肝或对照组大鼠相比,酒精性脂肪肝大鼠在I/R后出现严重的肝坏死。与对照组相比,2种脂肪肝模型的肝细胞凋亡增加。酒精性脂肪肝在I/R后1小时NF-κB结合活性迅速升高,随后TNF-α和CINC表达升高。相比之下,非酒精性脂肪肝在I/R后既没有NF-κB活化,也没有细胞因子诱导。我们的研究结果表明,酒精性脂肪肝可能在I/R后不同程度地诱导CINC的产生和肝坏死。此外,本研究表明,当中性粒细胞被激活并被募集到肝脏时,细胞凋亡负责肝坏死的进展。

项目成果

期刊论文数量(11)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Yamaguchi Y, Matsumura F, Wang FS, Akizuki E, Liang J, Matsuda T, Okabe K, Ohshiro H, Horiuchi T, Yamada S, Mori K, Ogawa M: "Neutrophil elastase enhances intercellular adhension molecule-1 expression."Transplantation. 65-12. 1622-1628 (1998)
Yamaguchi Y、Matsumura F、Wang FS、Akizuki E、Liang J、Matsuda T、Okabe K、Ohshiro H、Horiuchi T、Yamada S、Mori K、Okawa M:“中性粒细胞弹性蛋白酶增强细胞间粘附分子 1 的表达。”移植。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Ichiguchi O, Yamaguchi Y, Miyanari N, Mori K, Yamada S, Yagi J, Hikiji K, Yokoyama Y, Ogawa M.: "Enhanced hepatocyte growth factor expression associated with prolonged hepatic allograft survival recipients pretreated with donor-specific blood."Transplanta
Ichiguchi O、Yamaguchi Y、Miyanari N、Mori K、Yamada S、Yagi J、Hikiji K、Yokoyama Y、Okawa M.:“增强的肝细胞生长因子表达与用供体特异性血液预处理的同种异体肝移植受者延长存活相关。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Matsuda T, Yamaguchi Y, Matsumura F, Akizuki E, Okabe K, Ohshiro H, Ichiguchi O, Yamada S, Mori, K. Ogawa, M.: "Imunosuppressants decrease neutrophil chemoattractant and attenuate ischemia/reperfusion injury of the liver in rats."TTrauma. 44-3. 475-484 (1
Matsuda T、Yamaguchi Y、Matsumura F、Akizuki E、Okabe K、Ohshiro H、Ichiguchi O、Yamada S、Mori、K. Okawa, M.:“免疫抑制剂可减少中性粒细胞趋化剂并减轻大鼠肝脏缺血/再灌注损伤。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Yamada S, Matsuoka H, Harada Y, Momosaka Y, Izumi H, Kohmo K, Yamaguchi Y, Eto S: "Effects of long-term ethanol consumption on ability to produce cytokine-induced neutrophil chemoat-tractant-1 the rat liver and its gender difference"Alc Clin Exp Res. 23.
Yamada S、Matsuoka H、Harada Y、Momosaka Y、Izumi H、Kohmo K、Yamaguchi Y、Eto S:“长期摄入乙醇对大鼠肝脏及其产生细胞因子诱导的中性粒细胞趋化因子-1 的能力的影响
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Yamaguchi Y,Yamada S,et al.: "Peroxynitrite formation during rat hepatic allograft rejection."Hepatology. 29(3). 777-784 (1999)
Yamaguchi Y,Yamada S,et al.:“大鼠同种异体肝移植排斥过程中过氧亚硝酸盐的形成。”肝病学。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

YAMADA Shinwa其他文献

YAMADA Shinwa的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('YAMADA Shinwa', 18)}}的其他基金

A long graft survival of the steatotic liver after the inhibition of chemokine production and the remodeling of the altered extracellular matrix
抑制趋化因子产生和改变的细胞外基质重塑后脂肪变性肝脏的长期移植存活
  • 批准号:
    13670577
  • 财政年份:
    2001
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Escape from Inhibition of Liver Regeneration in Fibrotic Liver through The Modulation of Extracellular Matrix.
通过细胞外基质的调节摆脱纤维化肝脏中肝脏再生的抑制。
  • 批准号:
    07670637
  • 财政年份:
    1995
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Inhibition of Rejection Reaction by Modulating Actions of Adhesion Molecules on Sinusoidal Endothelial Cells in Rat Liver Allograft.
通过调节粘附分子对大鼠同种异体肝窦内皮细胞的作用来抑制排斥反应。
  • 批准号:
    05670509
  • 财政年份:
    1993
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似海外基金

GPR35: mechanisms of action and agonism as a potential therapeutic strategy for non-alcoholic fatty liver diseases
GPR35:作为非酒精性脂肪肝疾病潜在治疗策略的作用和激动机制
  • 批准号:
    MR/X008827/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Research Grant
AcceleRating the Translation of virtual twins towards a pErsonalised Management of fatty lIver patients (Artemis)
加速虚拟双胞胎向脂肪肝患者个性化管理的转化(Artemis)
  • 批准号:
    10109933
  • 财政年份:
    2024
  • 资助金额:
    $ 2.18万
  • 项目类别:
    EU-Funded
Perfluoroalkyl substances and non-alcoholic fatty liver disease in children: Leveraging magnetic resonance imaging to unravel potential mechanisms and exposure mixture effects
全氟烷基物质与儿童非酒精性脂肪肝:利用磁共振成像揭示潜在机制和暴露混合物效应
  • 批准号:
    10646759
  • 财政年份:
    2023
  • 资助金额:
    $ 2.18万
  • 项目类别:
An NADH-ChREBP axis in fatty liver disease and dyslipidemia
脂肪肝疾病和血脂异常中的 NADH-ChREBP 轴
  • 批准号:
    10564369
  • 财政年份:
    2023
  • 资助金额:
    $ 2.18万
  • 项目类别:
Development of Early Diagnostic Markers for Non-Alcoholic Fatty Liver Disease (NAFLD) and Investigation of Inflammatory Mechanisms of NAFLD
非酒精性脂肪性肝病(NAFLD)早期诊断标志物的开发及NAFLD炎症机制的研究
  • 批准号:
    23K07466
  • 财政年份:
    2023
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Tackling the fatty liver by targeting the gut
通过针对肠道来解决脂肪肝
  • 批准号:
    2869577
  • 财政年份:
    2023
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Studentship
Interaction between Genome and Heavy Metals in Nonalcoholic Fatty Liver Disease
非酒精性脂肪肝中基因组与重金属的相互作用
  • 批准号:
    10658148
  • 财政年份:
    2023
  • 资助金额:
    $ 2.18万
  • 项目类别:
AAV mediated gene knockdown of PIK3C2B as a therapeutic strategy for X-linked myotubular myopathy and fatty liver disease
AAV 介导的 PIK3C2B 基因敲低作为 X 连锁肌管肌病和脂肪肝的治疗策略
  • 批准号:
    10753786
  • 财政年份:
    2023
  • 资助金额:
    $ 2.18万
  • 项目类别:
Bacteriotherapy to treat non-alcoholic fatty liver disease
细菌疗法治疗非酒精性脂肪肝
  • 批准号:
    2893992
  • 财政年份:
    2023
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Studentship
Investigating folliculin as a regulator of VLDL-TG secretion in non-alcoholic fatty liver disease and steatohepatitis
研究卵泡素作为非酒精性脂肪肝和脂肪性肝炎中 VLDL-TG 分​​泌的调节剂
  • 批准号:
    10679361
  • 财政年份:
    2023
  • 资助金额:
    $ 2.18万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了